(Q33281867)

25 July 2017

1 reference

title

ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? (English)

1 reference

25 July 2017

1 reference

D Steinbach

1

1 reference

25 July 2017

O Legrand

series ordinal

2

1 reference

25 July 2017

publication date

12 April 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

21

1 reference

25 July 2017

issue

6

1 reference

25 July 2017

page(s)

1172-1176

1 reference

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Targeting multidrug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Contrary to adult patients, expression of the multidrug resistance gene (MDR1) fails to define a poor prognostic group in childhood AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

High Functional P-glycoprotein Activity is More Often Present in T-cell Acute Lymphoblastic Leukaemic Cells in Adults than in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

BCRP mRNA expression v. clinical outcome in 40 adult AML patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

High multidrug resistance protein activity in acute myeloid leukaemias is associated with poor response to chemotherapy and reduced patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Overexpression of lung-resistance protein and increased P-glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Multidrug resistance protein attenuates gemtuzumab ozogamicin-induced cytotoxicity in acute myeloid leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

MRP3, an organic anion transporter able to transport anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Alteration in copy numbers of genes as a mechanism for acquired drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

An in vivo propagated human acute myeloid leukemia expressing ABCA3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Cyclosporin A is a broad-spectrum multidrug resistance modulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

7 January 2021

The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

7 January 2021

Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

7 January 2021

Both Pgp and MRP1 activities using calcein-AM contribute to drug resistance in AML.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

7 January 2021

Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404692

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404692

1 reference

Dimensions Publication ID

25 July 2017

1034104794

0 references

1 reference